🇺🇸 FDA
Patent

US 6325999

Use of Fas ligand to suppress T-lymphocyte-mediated immune responses

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6325999 (Use of Fas ligand to suppress T-lymphocyte-mediated immune responses) held by The Regents of the University of Technology Office of Technology Transfer expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Technology Office of Technology Transfer
Grant date
Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P29/00